Roles of volume-sensitive Cl- channel in cisplatin-induced apoptosis in human epidermoid cancer cells

被引:60
作者
Ise, T
Shimizu, T
Lee, EL
Inoue, H
Kohno, K
Okada, Y [1 ]
机构
[1] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan
[2] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 8078555, Japan
关键词
Cl-; channel; apoptosis; cisplatin; cancer cell;
D O I
10.1007/s00232-005-0779-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The anti-cancer drug cisplatin induces apoptosis by damaging DNA. Since a stilbene-derivative blocker of Cl-/HCO3- exchangers and Cl- channels, SITS, is known to induce cisplatin resistance in a manner independent of intracellular pH and extracellular HCO3, we investigated the relation between cisplatin-induced apoptosis and Cl- channel activity in human adenocarcinoma KB cells. A stilbene derivative, DIDS, reduced cisplatin-induced caspase-3 activation and cell death, which were detected over 18 h after treatment with cisplatin. DIDS was also found to reduce sensitivity of KB cells to 5-day exposure to cisplatin. Whole-cell patch-clamp recordings showed that KB cells functionally express volume-sensitive outwardly rectifying (VSOR) Clchannels which are activated by osmotic cell swelling and sensitive to DIDS. Pretreatment of the cells with cisplatin for 12 h augmented the magnitude of VSOR Cl- current. Thus, it is concluded that cisplatin-induced cytotoxicity in KB cells is associated with augmented activity of a DIDS-sensitive VSOR Cl- channel and that blockade of this channel is, at least in part, responsible for cisplatin resistance induced by a stilbene derivative.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 36 条
[1]   ACTIVATION OF PROGRAMMED CELL-DEATH (APOPTOSIS) BY CISPLATIN, OTHER ANTICANCER DRUGS, TOXINS AND HYPERTHERMIA [J].
BARRY, MA ;
BEHNKE, CA ;
EASTMAN, A .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) :2353-2362
[2]  
CHU G, 1994, J BIOL CHEM, V269, P787
[3]   Cisplatin-induced renal cell apoptosis: Caspase 3-dependent and -independent pathways [J].
Cummings, BS ;
Schnellmann, RG .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01) :8-17
[4]   Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation [J].
Deschesnes, RG ;
Huot, J ;
Valerie, K ;
Landry, J .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (06) :1569-1582
[5]  
EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275
[6]   Phloretin differentially inhibits volume-sensitive and cyclic AMP-activated, but not Ca-activated, Cl- channels [J].
Fan, HT ;
Morishima, S ;
Kida, H ;
Okada, Y .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (07) :1096-1106
[7]   ACTIVE EFFLUX SYSTEM FOR CISPLATIN IN CISPLATIN-RESISTANT HUMAN KB CELLS [J].
FUJII, R ;
MUTOH, M ;
NIWA, K ;
YAMADA, K ;
AIKOU, T ;
NAKAGAWA, M ;
KUWANO, M ;
AKIYAMA, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (04) :426-433
[8]   Structure, recognition, and processing of cisplatin-DNA adducts [J].
Jamieson, ER ;
Lippard, SJ .
CHEMICAL REVIEWS, 1999, 99 (09) :2467-2498
[9]   ACTIVATION OF THE C-ABL TYROSINE KINASE IN THE STRESS-RESPONSE TO DNA-DAMAGING AGENTS [J].
KHARBANDA, S ;
REN, RB ;
PANDEY, P ;
SHAFMAN, TD ;
FELLER, SM ;
WEICHSELBAUM, RR ;
KUFE, DW .
NATURE, 1995, 376 (6543) :785-788
[10]   Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage [J].
Kharbanda, S ;
Pandey, P ;
Yamauchi, T ;
Kumar, S ;
Kaneki, M ;
Kumar, V ;
Bharti, A ;
Yuan, ZM ;
Ghanem, L ;
Rana, A ;
Weichselbaum, R ;
Johnson, G ;
Kufe, D .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (14) :4979-4989